Ajanta Pharma rises on launching Montelukast Sodium Oral Granules in US market

17 Nov 2015 Evaluate

Ajanta Pharma is currently trading at Rs. 1364.00, up by 29.45 points or 2.21% from its previous closing of Rs. 1334.55 on the BSE.

The scrip opened at Rs. 1366.00 and has touched a high and low of Rs. 1370.00 and Rs. 1352.00 respectively. So far 9,164 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1720.00 on 12-Aug-2015 and a 52 week low of Rs. 842.00 on 17-Nov-2014.

Last one week high and low of the scrip stood at Rs. 1470.00 and Rs. 1321.95 respectively. The current market cap of the company is Rs. 12,014.00 crore.

The promoters holding in the company stood at 73.78% while Institutions and Non-Institutions held 9.66% and 16.56% respectively.

Ajanta Pharma’s subsidiary - Ajanta Pharma USA Inc., has launched Montelukast Sodium Oral Granules (4mg), a bioequivalent generic version of SINGULAIR Granules, in the US market. The company offers Montelukast Granules in cartons containing 30 individual sachets.

The approval and launch of the Montelukast Granules is part of an ever-growing portfolio that Ajanta Pharma has developed for the US market. The United States Food & Drug Administration (USFDA) till date has granted five ANDA final approvals and two ANDA tentative approvals. An additional 19 ANDAs are pending approval from the USFDA.

Ajanta Pharma is a fully-integrated pharmaceutical company employing over 6,000 employees, engaged in developing, manufacturing and marketing of quality finished dosages across 35 countries.


Ajanta Pharma Share Price

2638.75 12.50 (0.48%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×